Roivant Sciences Ltd (ROIV)
NASDAQ · Healthcare
Roivant Sciences Ltd Revenue 2021–2026
Roivant Sciences Ltd annual/quarterly revenue history and growth rate from 2021 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Roivant Sciences Ltd revenue for the quarter ending December 31, 2025 was 2.0 M, a 77.83% decrease year-over-year.
- Roivant Sciences Ltd revenue for the twelve months ending December 31, 2025 was 14.8 M, a 53.41% decrease year-over-year.
- Roivant Sciences Ltd annual revenue for 2026 was 8.3 M, a 71.57% decrease from 2025.
- Roivant Sciences Ltd annual revenue for 2025 was 29.1 M, a 11.19% decrease from 2024.
- Roivant Sciences Ltd annual revenue for 2024 was 32.7 M, a 3.75% increase from 2023.
- Roivant Sciences Ltd annual revenue for 2023 was 31.5 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Roivant Sciences Ltd Market Cap — FAQ
Roivant Sciences Ltd (ROIV) market cap over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ROIV's market cap history?
The chart and table above show Roivant Sciences Ltd's market cap by year and by quarter, including the growth rate.